Viewing StudyNCT04977453



Ignite Creation Date: 2024-05-06 @ 4:23 PM
Last Modification Date: 2024-10-26 @ 2:09 PM
Study NCT ID: NCT04977453
Status: RECRUITING
Last Update Posted: 2024-02-22
First Post: 2021-07-09

Brief Title: GI-101 As a Single Agent or in Combination with Pembrolizumab Lenvatinib or Local Radiotherapy in Advanced Solid Tumors
Sponsor: GI Innovation Inc
Organization: GI Innovation Inc

Conditions & Keywords Data

Conditions:
Name
Advanced Solid Tumor
Metastatic Solid Tumor
Non-small Cell Lung Cancer
Head and Neck Squamous Cell Carcinoma
Renal Cell Carcinoma
Urinary Bladder Cancer
Melanoma
Sarcoma
Microsatellite Stable Colorectal Carcinoma
Merkel Cell Carcinoma
Esophageal Squamous Cell Carcinoma
Cervical Cancer
Vaginal Cancer
Vulvar Cancer
Keywords:
Name View
Radiotherapy View
GI-101GI-101A View
CD80-IgG4 Fc-IL2 variant View
Immunotherapy View
IL-2 View
Interleukin-2 View
Pembrolizumab View
Lenvatinib View